{"id":62806,"date":"2026-03-18T13:02:28","date_gmt":"2026-03-18T12:02:28","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/pelage-pharmaceuticals-pp405-and-its-impact-on-follicular-regeneration-to-be-presented-at-the-american-academy-of-dermatology-aad-annual-meeting-2026\/"},"modified":"2026-03-18T13:02:28","modified_gmt":"2026-03-18T12:02:28","slug":"pelage-pharmaceuticals-pp405-and-its-impact-on-follicular-regeneration-to-be-presented-at-the-american-academy-of-dermatology-aad-annual-meeting-2026","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/pelage-pharmaceuticals-pp405-and-its-impact-on-follicular-regeneration-to-be-presented-at-the-american-academy-of-dermatology-aad-annual-meeting-2026\/","title":{"rendered":"Pelage Pharmaceuticals\u2019 PP405 and its Impact on Follicular Regeneration to be Presented at the American Academy of Dermatology (AAD) Annual Meeting 2026"},"content":{"rendered":"<div>\n<p>LOS ANGELES&#8211;(BUSINESS WIRE)&#8211;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fpelagepharma.com%2F&amp;esheet=54453281&amp;newsitemid=20260317204870&amp;lan=en-US&amp;anchor=Pelage+Pharmaceuticals&amp;index=1&amp;md5=9a28fdb4caf3f09102c528601bb9b7db\" rel=\"nofollow\" shape=\"rect\">Pelage Pharmaceuticals<\/a>, a clinical-stage regenerative medicine biotechnology company, today announced that its first-in-class approach for treating hair loss with investigational medicine PP405 will be featured in a presentation about advances in the hair loss treatment landscape and regenerative mechanisms on Saturday, March 28th at the American Academy of Dermatology (AAD) Annual Meeting, taking place in Denver, Colorado.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20260317204870\/en\/2750605\/5\/Pelage_Logo-Optimized_BLACK.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260317204870\/en\/2750605\/22\/Pelage_Logo-Optimized_BLACK.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20260317204870\/en\/2750605\/5\/Pelage_Logo-Optimized_BLACK.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260317204870\/en\/2750605\/21\/Pelage_Logo-Optimized_BLACK.jpg\"><\/a><\/p>\n<p>\n<span class=\"bwuline\">Presentation Details:<\/span><\/p>\n<ul class=\"bwlistdisc\">\n<li>\n<b>Session: <\/b>S020 New Innovations in Dermatology: What Devices and Treatments You Will Be Using in the Next 1-5 Years<\/li>\n<li>\n<b>Presentation: <\/b>Emerging treatments for hair loss targeting dormant follicles<\/li>\n<li>\n<b>Presenter<\/b>: Arash Mostaghimi, M.D., MPH, FAAD, Vice Chair of Clinical Trials and Innovation, Brigham and Women\u2019s Hospital, Associate Professor, Harvard Medical School<\/li>\n<li>\n<b>Date<\/b>: Saturday, March 28 at 10:15 a.m. MST<\/li>\n<\/ul>\n<p>\nTreatments for hair loss and other dermatological conditions are undergoing an exciting period of innovation. Among the approaches with novel targets in clinical trials for androgenetic alopecia, PP405 is the most advanced and directly targets dormant hair follicle stem cells. As such, additional efficacy measurements may be helpful in assessing mechanisms aimed at follicle reactivation. Follicular units are natural groupings of 1-5 hair follicles sharing nerve and vascular structure that grow in bundles on the scalp. While hair loss treatments have historically focused on increasing hair growth in already active follicular units, PP405 aims to additionally drive terminal (non-vellus) hair growth from previously dormant follicular units. The Follicular Unit Count quantifies the number of active hair follicular units with at least one hair. This method provides a more meaningful benchmark for assessing novel hair loss therapies and their ability to activate new follicular units.<\/p>\n<p>\nThe company previously reported <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fpelagepharma.com%2Fpress-releases%2Fpelage-pharmaceuticals-announces-positive-phase-2a-clinical-trial-results-for-pp405-in-regenerative-hair-loss-therapy%2F&amp;esheet=54453281&amp;newsitemid=20260317204870&amp;lan=en-US&amp;anchor=Phase+2a+topline+results&amp;index=2&amp;md5=b497e229cd2b827116e36d68a58fb1b9\" rel=\"nofollow\" shape=\"rect\">Phase 2a topline results<\/a> in which PP405 was well tolerated in men and women with no systemic absorption in a randomized controlled study. While dosing was limited to four weeks, results in men with a higher degree of hair loss showed a rapid and significant clinical response by week eight, four weeks after completion of treatment. New terminal hair was demonstrated to grow from previously dormant follicular units. Pelage expects to initiate late-stage studies in 2026, designed to further evaluate the safety and efficacy of PP405 in patients with androgenetic alopecia.<\/p>\n<p>\n<b>About Pelage Pharmaceuticals<\/b><\/p>\n<p>\nPelage Pharmaceuticals is a clinical-stage regenerative medicine biotechnology company developing first-in-class treatments for hair loss. With a focus on stem cell biology and metabolism, Pelage is advancing a novel class of therapies designed to reactivate dormant hair follicle stem cells and restore the body\u2019s natural ability to grow hair. Its lead program, PP405, is currently in clinical trials for androgenetic alopecia. With its rigorous scientific foundation, Pelage is pioneering first-in-class hair-growth solutions for men and women of all hair types experiencing hair loss.<\/p>\n<p>\nFor more information about Pelage, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fpelagepharma.com%2F&amp;esheet=54453281&amp;newsitemid=20260317204870&amp;lan=en-US&amp;anchor=https%3A%2F%2Fpelagepharma.com%2F&amp;index=3&amp;md5=d9985bd8e19a1a1443d2359dd4d81208\" rel=\"nofollow\" shape=\"rect\">https:\/\/pelagepharma.com\/<\/a> and follow us on <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fpelage-pharmaceuticals%2F&amp;esheet=54453281&amp;newsitemid=20260317204870&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=4&amp;md5=308a128afb60179c313b0f552b45bd90\" rel=\"nofollow\" shape=\"rect\">LinkedIn<\/a> and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fx.com%2FPelagePharma&amp;esheet=54453281&amp;newsitemid=20260317204870&amp;lan=en-US&amp;anchor=X&amp;index=5&amp;md5=1be6be126036d749611832d713d28222\" rel=\"nofollow\" shape=\"rect\">X<\/a>. To learn more about upcoming trials for PP405, sign up for updates at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.pelagepp405.com%2F&amp;esheet=54453281&amp;newsitemid=20260317204870&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.pelagepp405.com%2F&amp;index=6&amp;md5=bb78e3fc42d752be063045fa3c42dca3\" rel=\"nofollow\" shape=\"rect\">https:\/\/www.pelagepp405.com\/<\/a>.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nBusiness development and investor inquiries: <a target=\"_blank\" href=\"m&#97;&#105;&#108;&#x74;&#x6f;&#x3a;in&#102;&#111;&#x40;&#x70;&#x65;&#x6c;ag&#101;&#112;&#x68;&#x61;&#x72;&#x6d;a&#46;&#99;&#111;&#x6d;\" rel=\"nofollow\" shape=\"rect\">&#105;&#x6e;&#102;&#x6f;&#64;&#x70;e&#x6c;a&#x67;e&#112;&#x68;&#97;&#x72;&#109;&#x61;&#46;&#x63;o&#x6d;<\/a><br \/>Media inquiries: <a target=\"_blank\" href=\"m&#97;&#105;&#x6c;&#x74;&#x6f;:m&#101;&#100;&#x69;&#x61;&#x40;p&#101;&#108;&#97;&#x67;&#x65;&#x70;h&#97;&#114;&#x6d;&#x61;&#x2e;co&#109;\" rel=\"nofollow\" shape=\"rect\">&#x6d;&#101;d&#x69;&#97;&#64;&#x70;&#x65;&#108;&#x61;&#x67;&#101;p&#x68;&#97;r&#x6d;&#x61;&#46;&#x63;&#x6f;&#109;<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>LOS ANGELES&#8211;(BUSINESS WIRE)&#8211;Pelage Pharmaceuticals, a clinical-stage regenerative medicine biotechnology company, today announced that its first-in-class approach for treating hair loss with investigational medicine PP405 will be featured in a presentation about advances in the hair loss treatment landscape and regenerative mechanisms on Saturday, March 28th at the American Academy of Dermatology (AAD) Annual Meeting, taking &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/pelage-pharmaceuticals-pp405-and-its-impact-on-follicular-regeneration-to-be-presented-at-the-american-academy-of-dermatology-aad-annual-meeting-2026\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62806","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pelage Pharmaceuticals\u2019 PP405 and its Impact on Follicular Regeneration to be Presented at the American Academy of Dermatology (AAD) Annual Meeting 2026 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/pelage-pharmaceuticals-pp405-and-its-impact-on-follicular-regeneration-to-be-presented-at-the-american-academy-of-dermatology-aad-annual-meeting-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pelage Pharmaceuticals\u2019 PP405 and its Impact on Follicular Regeneration to be Presented at the American Academy of Dermatology (AAD) Annual Meeting 2026 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"LOS ANGELES&#8211;(BUSINESS WIRE)&#8211;Pelage Pharmaceuticals, a clinical-stage regenerative medicine biotechnology company, today announced that its first-in-class approach for treating hair loss with investigational medicine PP405 will be featured in a presentation about advances in the hair loss treatment landscape and regenerative mechanisms on Saturday, March 28th at the American Academy of Dermatology (AAD) Annual Meeting, taking ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/pelage-pharmaceuticals-pp405-and-its-impact-on-follicular-regeneration-to-be-presented-at-the-american-academy-of-dermatology-aad-annual-meeting-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-18T12:02:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20260317204870\/en\/2750605\/22\/Pelage_Logo-Optimized_BLACK.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pelage-pharmaceuticals-pp405-and-its-impact-on-follicular-regeneration-to-be-presented-at-the-american-academy-of-dermatology-aad-annual-meeting-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pelage-pharmaceuticals-pp405-and-its-impact-on-follicular-regeneration-to-be-presented-at-the-american-academy-of-dermatology-aad-annual-meeting-2026\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Pelage Pharmaceuticals\u2019 PP405 and its Impact on Follicular Regeneration to be Presented at the American Academy of Dermatology (AAD) Annual Meeting 2026\",\"datePublished\":\"2026-03-18T12:02:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pelage-pharmaceuticals-pp405-and-its-impact-on-follicular-regeneration-to-be-presented-at-the-american-academy-of-dermatology-aad-annual-meeting-2026\\\/\"},\"wordCount\":515,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pelage-pharmaceuticals-pp405-and-its-impact-on-follicular-regeneration-to-be-presented-at-the-american-academy-of-dermatology-aad-annual-meeting-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260317204870\\\/en\\\/2750605\\\/22\\\/Pelage_Logo-Optimized_BLACK.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pelage-pharmaceuticals-pp405-and-its-impact-on-follicular-regeneration-to-be-presented-at-the-american-academy-of-dermatology-aad-annual-meeting-2026\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pelage-pharmaceuticals-pp405-and-its-impact-on-follicular-regeneration-to-be-presented-at-the-american-academy-of-dermatology-aad-annual-meeting-2026\\\/\",\"name\":\"Pelage Pharmaceuticals\u2019 PP405 and its Impact on Follicular Regeneration to be Presented at the American Academy of Dermatology (AAD) Annual Meeting 2026 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pelage-pharmaceuticals-pp405-and-its-impact-on-follicular-regeneration-to-be-presented-at-the-american-academy-of-dermatology-aad-annual-meeting-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pelage-pharmaceuticals-pp405-and-its-impact-on-follicular-regeneration-to-be-presented-at-the-american-academy-of-dermatology-aad-annual-meeting-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260317204870\\\/en\\\/2750605\\\/22\\\/Pelage_Logo-Optimized_BLACK.jpg\",\"datePublished\":\"2026-03-18T12:02:28+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pelage-pharmaceuticals-pp405-and-its-impact-on-follicular-regeneration-to-be-presented-at-the-american-academy-of-dermatology-aad-annual-meeting-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pelage-pharmaceuticals-pp405-and-its-impact-on-follicular-regeneration-to-be-presented-at-the-american-academy-of-dermatology-aad-annual-meeting-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pelage-pharmaceuticals-pp405-and-its-impact-on-follicular-regeneration-to-be-presented-at-the-american-academy-of-dermatology-aad-annual-meeting-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260317204870\\\/en\\\/2750605\\\/22\\\/Pelage_Logo-Optimized_BLACK.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260317204870\\\/en\\\/2750605\\\/22\\\/Pelage_Logo-Optimized_BLACK.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pelage-pharmaceuticals-pp405-and-its-impact-on-follicular-regeneration-to-be-presented-at-the-american-academy-of-dermatology-aad-annual-meeting-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pelage Pharmaceuticals\u2019 PP405 and its Impact on Follicular Regeneration to be Presented at the American Academy of Dermatology (AAD) Annual Meeting 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pelage Pharmaceuticals\u2019 PP405 and its Impact on Follicular Regeneration to be Presented at the American Academy of Dermatology (AAD) Annual Meeting 2026 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/pelage-pharmaceuticals-pp405-and-its-impact-on-follicular-regeneration-to-be-presented-at-the-american-academy-of-dermatology-aad-annual-meeting-2026\/","og_locale":"en_US","og_type":"article","og_title":"Pelage Pharmaceuticals\u2019 PP405 and its Impact on Follicular Regeneration to be Presented at the American Academy of Dermatology (AAD) Annual Meeting 2026 - Pharma Trend","og_description":"LOS ANGELES&#8211;(BUSINESS WIRE)&#8211;Pelage Pharmaceuticals, a clinical-stage regenerative medicine biotechnology company, today announced that its first-in-class approach for treating hair loss with investigational medicine PP405 will be featured in a presentation about advances in the hair loss treatment landscape and regenerative mechanisms on Saturday, March 28th at the American Academy of Dermatology (AAD) Annual Meeting, taking ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/pelage-pharmaceuticals-pp405-and-its-impact-on-follicular-regeneration-to-be-presented-at-the-american-academy-of-dermatology-aad-annual-meeting-2026\/","og_site_name":"Pharma Trend","article_published_time":"2026-03-18T12:02:28+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20260317204870\/en\/2750605\/22\/Pelage_Logo-Optimized_BLACK.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/pelage-pharmaceuticals-pp405-and-its-impact-on-follicular-regeneration-to-be-presented-at-the-american-academy-of-dermatology-aad-annual-meeting-2026\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/pelage-pharmaceuticals-pp405-and-its-impact-on-follicular-regeneration-to-be-presented-at-the-american-academy-of-dermatology-aad-annual-meeting-2026\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Pelage Pharmaceuticals\u2019 PP405 and its Impact on Follicular Regeneration to be Presented at the American Academy of Dermatology (AAD) Annual Meeting 2026","datePublished":"2026-03-18T12:02:28+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/pelage-pharmaceuticals-pp405-and-its-impact-on-follicular-regeneration-to-be-presented-at-the-american-academy-of-dermatology-aad-annual-meeting-2026\/"},"wordCount":515,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/pelage-pharmaceuticals-pp405-and-its-impact-on-follicular-regeneration-to-be-presented-at-the-american-academy-of-dermatology-aad-annual-meeting-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260317204870\/en\/2750605\/22\/Pelage_Logo-Optimized_BLACK.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/pelage-pharmaceuticals-pp405-and-its-impact-on-follicular-regeneration-to-be-presented-at-the-american-academy-of-dermatology-aad-annual-meeting-2026\/","url":"https:\/\/pharma-trend.com\/en\/pelage-pharmaceuticals-pp405-and-its-impact-on-follicular-regeneration-to-be-presented-at-the-american-academy-of-dermatology-aad-annual-meeting-2026\/","name":"Pelage Pharmaceuticals\u2019 PP405 and its Impact on Follicular Regeneration to be Presented at the American Academy of Dermatology (AAD) Annual Meeting 2026 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/pelage-pharmaceuticals-pp405-and-its-impact-on-follicular-regeneration-to-be-presented-at-the-american-academy-of-dermatology-aad-annual-meeting-2026\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/pelage-pharmaceuticals-pp405-and-its-impact-on-follicular-regeneration-to-be-presented-at-the-american-academy-of-dermatology-aad-annual-meeting-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260317204870\/en\/2750605\/22\/Pelage_Logo-Optimized_BLACK.jpg","datePublished":"2026-03-18T12:02:28+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/pelage-pharmaceuticals-pp405-and-its-impact-on-follicular-regeneration-to-be-presented-at-the-american-academy-of-dermatology-aad-annual-meeting-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/pelage-pharmaceuticals-pp405-and-its-impact-on-follicular-regeneration-to-be-presented-at-the-american-academy-of-dermatology-aad-annual-meeting-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/pelage-pharmaceuticals-pp405-and-its-impact-on-follicular-regeneration-to-be-presented-at-the-american-academy-of-dermatology-aad-annual-meeting-2026\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20260317204870\/en\/2750605\/22\/Pelage_Logo-Optimized_BLACK.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20260317204870\/en\/2750605\/22\/Pelage_Logo-Optimized_BLACK.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/pelage-pharmaceuticals-pp405-and-its-impact-on-follicular-regeneration-to-be-presented-at-the-american-academy-of-dermatology-aad-annual-meeting-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Pelage Pharmaceuticals\u2019 PP405 and its Impact on Follicular Regeneration to be Presented at the American Academy of Dermatology (AAD) Annual Meeting 2026"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62806","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62806"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62806\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62806"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62806"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62806"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}